{"slideshow_credits": null, "snippet": "Defensive tactics can serve legitimate business interests, but many invite criticism that companies are eager to avoid, Reynolds Holding writes in Reuters Breakingviews.", "abstract": "Defensive tactics can serve legitimate business interests, but many invite criticism that companies are eager to avoid, Reynolds Holding writes in Reuters Breakingviews.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Reynolds", "role": "reported", "lastname": "HOLDING", "rank": 1, "organization": ""}], "original": "By REYNOLDS HOLDING"}, "web_url": "http://dealbook.nytimes.com/2014/12/17/anti-takeover-defense-measures-often-hurt-investors/", "lead_paragraph": null, "headline": {"main": "Anti-Takeover Measures Often Hurt Investors", "kicker": "DealBook"}, "_id": "5491d43138f0d80edc34667b", "word_count": "380", "multimedia": [{"height": 126, "url": "images/2014/11/18/business/dbpix-allergan1/dbpix-allergan1-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/11/18/business/dbpix-allergan1/dbpix-allergan1-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 401, "url": "images/2014/11/18/business/dbpix-allergan1/dbpix-allergan1-articleLarge.jpg", "legacy": {"xlarge": "images/2014/11/18/business/dbpix-allergan1/dbpix-allergan1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "401"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/11/18/business/dbpix-allergan1/dbpix-allergan1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/11/18/business/dbpix-allergan1/dbpix-allergan1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-12-17T14:01:12Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Allergan Inc", "name": "organizations", "rank": "1"}, {"value": "Healthways Inc", "name": "organizations", "rank": "2"}, {"value": "Pershing Square Capital Management", "name": "organizations", "rank": "3"}, {"value": "Valeant Pharmaceuticals International Inc", "name": "organizations", "rank": "4"}, {"value": "Boards of Directors", "name": "subject", "rank": "1"}, {"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "rank": "2"}, {"value": "Shareholder Rights and Activism", "name": "subject", "rank": "3"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}